Thacker 2003.

Methods	Study design: prospective, randomized study Study duration: not stated Follow‐up: 60 min
Participants	Country: not stated Setting: not stated Annual census: not stated Inclusion criteria: adults undergoing treatment for nausea Exclusion criteria: pregnancy Number: treatment group 1: 16; treatment group 2: 12 Mean age (years): total 33.8 (95% CI 29.3 to 38.4), not reported separately Sex (M/W): 63% women, not reported separately
Interventions	Treatment group 1: droperidol 1.25 mg IV Treatment group 2: metoclopramide 10 mg IV
Outcomes	Outcomes: nausea VAS, somnolence VAS, adverse effects, QTc
Notes	Abstract only available Results: mean change in nausea VAS: group 1 (‐46.9 mm, 95% CI ‐55.3 to ‐38.5); group 2 (‐45.2 mm, 95% CI ‐62.6 to ‐27.9). Akathisia reported in 2 (12.5%) participants in group 1 and 1 (9.1%) participants in group 2